Y-mAbs Therapeutics, Inc. (YMAB)

NASDAQ: YMAB · IEX Real-Time Price · USD
14.91
-0.22 (-1.45%)
Jul 1, 2022 11:57 AM EDT - Market open

Stock Price Forecast

According to 14 stock analysts, the average 12-month stock price forecast for YMAB stock is $28.73, which predicts an increase of 92.69%. The lowest target is $15.15 and the highest is $66.15. On average, analysts rate YMAB stock as a buy.
Analyst Consensus: Buy
Target Low Average Median High
Price $15.15 $28.73 $21.93 $66.15
Change +1.61% +92.69% +47.08% +343.66%

Analyst Ratings

The average analyst rating for YMAB stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '22Feb '22Mar '22Apr '22May '22Jun '22
Strong Buy 556666
Buy 555555
Hold 333333
Sell 000000
Strong Sell 000000
Total 131314141414

Financial Forecast

Revenue This Year
64.73M
Increased by 85.48%
Revenue Next Year
99.74M
Increased by 54.09%
EPS This Year
-1.83
EPS Next Year
-1.65
Year 2017201820192020202120222023202420252026
Revenue
---20.75M34.90M64.73M99.74M174.36M281.13M462.33M
Revenue Growth
----
68.18%
85.48%
54.09%
74.82%
61.23%
64.46%
EPS
-0.99-1.50-2.30-2.97-1.28-1.83-1.65-0.67-0.89-1.19
EPS Growth
----------
No. Analysts -----98733

Revenue Forecast

Revenue 20222023202420252026
High 122.7M 183.0M 361.7M 295.2M 480.8M
Avg 64.7M 99.7M 174.4M 281.1M 462.3M
Low 47.0M 67.6M 82.3M 272.7M 448.5M

Revenue Growth

Revenue Growth 20222023202420252026
High
235.2%
182.7%
262.7%
69.3%
71.0%
Avg
76.9%
54.1%
74.8%
61.2%
64.5%
Low
28.5%
4.5%
-17.5%
56.4%
59.5%

EPS Forecast

EPS 20222023202420252026
High -0.44 -0.47 2.31 -0.93 -1.24
Avg -1.83 -1.65 -0.67 -0.89 -1.19
Low -2.60 -2.36 -1.80 -0.86 -1.16

EPS Growth

EPS Growth 20222023202420252026
High - - - - -
Avg - - - - -
Low - - - - -